Sacuvia 50 mg Tablets (Sacubitril + Valsartan)

Sacuvia combines Sacubitril and Valsartan, a modern and highly effective treatment for heart failure. This combination belongs to the class of ARNIs (Angiotensin Receptor Neprilysin Inhibitors), which has been proven to reduce hospitalizations and improve survival in patients with reduced ejection fraction (HFrEF).

This medication helps the heart pump more efficiently, reduces strain on the cardiovascular system, and improves overall heart function.

Specifications:

-

Form: Film-coated tablets

-

Strength: 50 mg

-

Pack Size: 14 tablets

-

Active Ingredients: Sacubitril + Valsartan

-

Route: Oral

Uses / Indications:

-

Treatment of chronic heart failure

-

Reduces the risk of cardiovascular death

-

Prevents hospital admissions in heart failure patients

-

Improves heart efficiency and function

Key Benefits:

-

Reduces shortness of breath and fatigue

-

Helps stabilize heart rhythm and function

-

Evidence-based reduction in overall mortality

-

Improves quality of life for heart failure patients

Important Notes:

-

Must be prescribed and monitored by a cardiologist or physician

-

Not for use with ACE inhibitors (risk of angioedema)

-

Monitor blood pressure and kidney function regularly

-

Not recommended during pregnancy

Possible Side Effects:

-

Low blood pressure

-

Dizziness

-

Increased potassium levels

-

Kidney function changes

-

Rare: swelling of face/lips (angioedema)

Seek immediate medical attention if severe reactions occur.